2000-26 Was Sie schon lange über das HbA1c wissen wollten ...

Literatur
Schweiz Med Wochenschr 2000;130: Nr 26
Fortbildung
1 Holmquist WR, Schroeder WA. A new N-terminal blocking
group involving a Schiff base in hemoglobin A1c. Biochemistry
1966;5:2489–2503.
2 Bookchin RM, Gallop PM. Structure of hemoglobin A1c:
nature of the N-terminal beta chain blocking group. Biochem
Biophys Res Commun 1968;32:86–93.
3 Huisman THJ, Dozy AM. Studies on the heterogeneity of
hemoglobin. V. Binding of hemoglobin with oxidized glutathione.
J Lab Clin Med 1962;60:302–19.
4 Rahbar S, Blumenfeld O, Ranney HM. Studies of an unusual
hemoglobin in patients with diabetes mellitus. Biochem
Biophys Res Commun 1969;36:838–43.
5 Trivelli LA, Ranney HM, Lai H-T. Hemoglobin components
in patients with diabetes mellitus. N Engl J Med
1971;248:353–7.
6 Bunn HF, Haney DN, Kamin S, Gabbay KH, Gallop PM.
The biosynthesis of human hemoglobin A1c. J Clin Invest
1976;57:1652–9.
7 Koenig RJ, Peterson CM, Kilo C, Cerami A, Williamson
JR. Hemoglobin A1c as an indicator of the degree of glucose
intolerance in diabetes. Diabetes 1976;25:230–2.
8 Koenig RJ, Peterson CM, Jones RL, Saudek C, Lehrman
M, Cerami A. Correlation of glucose regulation and
hemoglobin A1c in diabetes mellitus. N Engl J Med 1976;
295:417–20.
9 Gabbay KH, Hasty K, Breslow JL, Ellison RC, Bunn HF,
Gallop PM. Glycosylated hemoglobins and long-term
blood glucose control in diabetes mellitus. J Clin Endocrinol
Metab 1977;44:859–64.
10 Svendsen PA, Lauritzen T, Søegaard U, Nerup J. Glycosylated
haemoglobin and steady-state mean blood glucose
concentration in Type 1 (insulin-dependent) diabetes. Diabetologia
1982;23:403–5.
11 Jovanovic L, Peterson CM. The clinical utility of glycosylated
hemoglobin. Am J Med 1981;70:331–8.
12 Goldstein DE, Little RR, Wiedmeyer HM, England JD,
McKenzie EM. Glycated hemoglobin: methodologies
and clinical applications. Clin Chem 1986;32(Suppl
10):B64–B70.
13 Weykamp CW, Miedema K, de Haan T, Doelman CJ.
Carbamylated hemoglobin interference in glycohemoglobin
assays. Clin Chem 1999;45:438–40.
14 Gonen B, Rubenstein A, Rochman H, Tanega SP, Horwitz
DL. Haemoglobin A1: an indicator of the metabolic control
of diabetic patients. Lancet 1977;2:734–7.
15 Kaplan LA, Cline D, Gartside P, Burstein S, Sperling M,
Stein EA. Hemoglobin A1 in hemolysates from healthy
and insulin-dependent diabetic children, as determined
with a temperature-controlled minicolumn assay. Clin
Chem 1982;28:13–8.
16 Goldstein DE. Is glycosylated hemoglobin clinically useful?
N Engl J Med 1984;310:384–5.
17 Larsen ML, Horder M, Mogensen EF. Effect of long-term
monitoring of glycosylated hemoglobin levels in insulindependent
diabetes mellitus. N Engl J Med 1990;323:
1021–5.
18 American Diabetes Association. Standards of medical
care for patients with diabetes mellitus. Diabetes Care
1994;17:616–23.
19 The DCCT Research Group. The effect of intensive treatment
of diabetes on the development and progression of
long-term complications in insulin-dependent diabetes
mellitus. N Engl J Med 1993;329:977–86.
20 UK Prospective Diabetes Study (UKPDS) Group. Intensive
blood-glucose control with sulphonylureas or insulin
compared with conventional treatment and risk of complications
in patients with type 2 diabetes (UKPDS 33).
Lancet 1998;352:837–53.
21 Flückiger R, Berger W. Assessment of long-term glycemia:
nonenzymatic protein glycosylation. Progr Clin Biochem
Med 1986;3:14–9.
22 McDonald MJ, Shapiro R, Bleichman M, Solway J, Bunn
HF. Glycosylated minor components of human adult
hemoglobin. Purification, identification and partial structural
analysis. J Biol Chem 1978;253:2327–32.
23 Huisman TH, Henson JB, Wilson JB. A new high-performance
liquid chromatographic procedure to quantitate
hemoglobin A1c and other minor hemoglobins in blood of
normal, diabetic, and alcoholic individuals. J Lab Clin
Med 1983;102:163–73.
24 Allen DW, Schroeder WA, Balog J. Observations on the
chromatographic heterogeneity of normal and fetal human
hemoglobin: a study of the effects of crystallization and
chromatography on the heterogeneity and isoleucine
content. JACS 1958;80:1628–34.
25 John WG, Bullock DG, MacKenzie F. Methods for the
analysis of glycated haemoglobins: what is being measured?
Diabet Med 1992;9:15–9.
26 Berger W, Flückiger R. Bestimmung der glykosylierten
Hämoglobine HbA1(c) mit kommerziellen Methoden; Folgerungen
aus einem Methodenvergleich. Schweiz Ärztezeitung
1984;34:1620–2.
27 Koenig RJ, Peterson CM, Jones RL, Saudek C, Lehrman
M, Cerami A. Correlation of glucose regulation and hemoglobin
A1c in diabetes mellitus. N Engl J Med 1976;
295:417–20.
28 Gabbay KH, Hasty K, Breslow JL, Ellison RC, Bunn HF,
Gallop PM. Glycosylated hemoglobins and long-term
blood glucose control in diabetes mellitus. J Clin Endocrinol
Metab 1977;44:859–64.
29 James TM, Davis JE, McDonald JM, Santiago JV, Ladenson
JH. Comparison of hemoglobin A1c and hemoglobin
A1 in diabetic patients. Clin Biochem 1981;14:25–7.
30 Mortensen HB, Svendsen PA. Determination of haemoglobin
A1c by iso-electric focusing. Effect of incubation of
erythrocytes and comparison of results obtained by ionexchange
chromatography. Scand J Clin Lab Invest 1981;
41:451–5.
31 Carrera T, Bonamusa L, Almirall L, Navarro JM. Should
age and sex be taken into account in the determination of
HbA1c reference range? Diabetes Care 1998;21:2193.
32 Nakashima K, Nishizaki O, Andoh Y. Acceleration of
hemoglobin glycation with aging. Clin Chim Acta 1993;
214:111–8.
33 Hashimoto Y, Futamura A, Ikushima M. Effect of aging on
HbA1c in a working male Japanese population. Diabetes
Care 1995;18:1337–40.
34 Yang YC, Lu FH, Wu JS, Chang CJ. Age and sex effects on
HbA1c: a study in a healthy Chinese population. Diabetes
Care 1997;20:988–91.
35 Carrera T, Bonamusa L, Perich C, Juve R, Cosculluela R,
Almirall L, et al. Effect of aging on HbA1c reference values
determined by HPLC in an HA-8140 system [abstract].
Clin Chem 1997;43(Suppl 6):S138.
36 Stickland MH, Paton RC, Wales JK. Haemoglobin A1c
concentrations in men and women with diabetes. Br
Med J 1984;289:733.
37 Hindle EJ, Rostron GM, Gatt JA. Haemoglobin A1c concentrations
in men and women with diabetes. Br Med J
1984;289:1001.
38 Flückiger R, et al. Nichtenzymatische Glykosylierung von
Proteinen bei Diabetes mellitus. Stuttgart: Georg Thieme
Verlag; 1989.
39 American Diabetes Association. Standards of medical
care for patients with diabetes mellitus. Diabetes Care
1996;19:S8–S15.
40 Walinder O, Wibell L, Tuvemo T. Relation between hemoglobin
A1 and determinations of glucose in diabetics treated
with and without insulin. Diabetes Metab 1980;6:251–
5.
41 Pecoraro RE, Chen MS, Porte D Jr. Glycosylated hemoglobin
and fasting plasma glucose in the assessment of
outpatient glycemic control in NIDDM. Diabetes Care
1982;5:592–9.
1003